Subscribe To
Cenovus: the best oil stock for 2022
Cenovus is my largest position and I believe it is the best way to play a strong crude environment in 2...
December 27, 2021, 1:27 pm
Astrazeneca's covid-19 antibody effective against omicron variant
New preclinical data released by AstraZeneca Plc (NASDAQ: AZN) shows that its long-acting antibody Evus...
December 16, 2021, 1:27 pm
Astrazeneca's covid-19 antibody effective against omicron variant
New preclinical data released by AstraZeneca Plc (NASDAQ: AZN) shows that its long-acting antibody Evus...
December 16, 2021, 1:27 pm
Astrazeneca's covid-19 antibody effective against omicron variant
New preclinical data released by AstraZeneca Plc (NASDAQ: AZN) shows that its long-acting antibody Evus...
December 16, 2021, 1:27 pm
British american tobacco: vuse dividend insurance
BTI is clearly undervalued given its earnings growth and low share price. BTI has been burned by currency fluctuations which is hiding growth....
November 28, 2021, 10:18 am
British american tobacco: vuse dividend insurance
BTI is clearly undervalued given its earnings growth and low share price. BTI has been burned by currency fluctuations which is hiding growth....
November 28, 2021, 10:18 am
British american tobacco: vuse dividend insurance
BTI is clearly undervalued given its earnings growth and low share price. BTI has been burned by currency fluctuations which is hiding growth....
November 28, 2021, 10:18 am
Cenovus energy: bigger, better and stronger
Operational excellence and execution....
October 7, 2021, 12:26 pm
Cenovus energy: bigger, better and stronger
Operational excellence and execution....
October 7, 2021, 12:26 pm
Cenovus energy: bigger, better and stronger
Operational excellence and execution....
October 7, 2021, 12:26 pm
Genentech to present new data on ocrevus (ocrelizumab) in multiple sclerosis and enspryng (satralizumab-mwge) in neuromyelitis optica spectrum disorder at ectrims 2021
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that new Ocre...
October 5, 2021, 1:00 am
Roche to present new data on ocrevus in multiple sclerosis and enspryng in neuromyelitis optica spectrum disorder at ectrims 2021
Basel, 5 October 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that new OCREvus® (ocrelizu...
October 5, 2021, 1:00 am
Genentech to present new data on ocrevus (ocrelizumab) in multiple sclerosis and enspryng (satralizumab-mwge) in neuromyelitis optica spectrum disorder at ectrims 2021
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that new Ocre...
October 5, 2021, 1:00 am
Roche to present new data on ocrevus in multiple sclerosis and enspryng in neuromyelitis optica spectrum disorder at ectrims 2021
Basel, 5 October 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that new OCREvus® (ocrelizu...
October 5, 2021, 1:00 am
Genentech to present new data on ocrevus (ocrelizumab) in multiple sclerosis and enspryng (satralizumab-mwge) in neuromyelitis optica spectrum disorder at ectrims 2021
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that new Ocre...
October 5, 2021, 1:00 am
Roche to present new data on ocrevus in multiple sclerosis and enspryng in neuromyelitis optica spectrum disorder at ectrims 2021
Basel, 5 October 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that new OCREvus® (ocrelizu...
October 5, 2021, 1:00 am
Genentech to present new data on ocrevus (ocrelizumab) in multiple sclerosis and enspryng (satralizumab-mwge) in neuromyelitis optica spectrum disorder at ectrims 2021
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that new Ocre...
October 5, 2021, 1:00 am
Roche to present new data on ocrevus in multiple sclerosis and enspryng in neuromyelitis optica spectrum disorder at ectrims 2021
Basel, 5 October 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that new OCREvus® (ocrelizu...
October 5, 2021, 1:00 am
Genentech to present new data on ocrevus (ocrelizumab) in multiple sclerosis and enspryng (satralizumab-mwge) in neuromyelitis optica spectrum disorder at ectrims 2021
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that new Ocre...
October 5, 2021, 1:00 am
Genentech to present new data on ocrevus (ocrelizumab) in multiple sclerosis and enspryng (satralizumab-mwge) in neuromyelitis optica spectrum disorder at ectrims 2021
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that new Ocre...
October 5, 2021, 1:00 am